WallStreetZenWallStreetZen

NASDAQ: QNRX
Quoin Pharmaceuticals Ltd Stock

Overview
ForecastEarningsRevenueDividendOwnership
$6.77+0.19 (+2.89%)
Updated Apr 30, 2025
QNRX Price
$6.77
Fair Value Price
N/A
Market Cap
$6.97M
52 Week Low
$3.33
52 Week High
$31.40
P/E
N/A
P/B
0.76x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$8.96M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.71
Operating Cash Flow
-$8M
Beta
2.13
Next Earnings
May 7, 2025
Ex-Dividend
N/A
Next Dividend
N/A

QNRX Overview

Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine QNRX's potential to beat the market

DSell
  • Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
View All “A” Zen Rated Stocks
→

Zen Rating Component Grades

F
Value
C
Growth
F
Momentum
C
Sentiment
C
Safety
D
Financials
F
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
QNRX
Ranked#239 of 462

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
Protalix Biotherapeutics (PLX)
$3.07A
Aurinia Pharmaceuticals (AUPH)
$8.24A
Catalyst Pharmaceuticals (CPRX)
$24.29A
View Top Biotech Stocks

Be the first to know about important QNRX news, forecast changes, insider trades & much more!

QNRX News

Overview

Due Diligence Score

–
Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how QNRX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

QNRX is good value based on its book value relative to its share price (0.76x), compared to the US Biotechnology industry average (4.45x)
P/B vs Industry Valuation
QNRX's cash burn is expected to be positive in the next year ($12.73M), even accounting for increasing cash burn (62%)
Interest Coverage Financials
QNRX's short-term assets ($14.93M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
There are 30 more QNRX due diligence checks available for Premium users.

Valuation

QNRX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.76x
Industry
4.45x
QNRX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

QNRX's financial health

Profit margin

Revenue
$0.0
Net Income
-$2.3M
Profit Margin
0%
QNRX's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$15.7M
Liabilities
$6.5M
Debt to equity
0.71
QNRX's short-term assets ($14.93M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
QNRX's short-term assets ($14.93M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
QNRX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
QNRX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.2M
Investing
-$3.2M
Financing
$5.9M
QNRX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

QNRX vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
QNRXD$6.97M+2.87%N/A0.76x
CHRO–$6.96M-10.94%-0.80x-2.56x
GNPX–$7.00M+3.57%-0.05x4.32x
APLM–$7.27M+2.49%-0.12x1.49x
INDP–$6.64M-2.13%-0.29x1.68x
View Top Biotech Stocks

Quoin Pharmaceuticals Stock FAQ

What is Quoin Pharmaceuticals's quote symbol?

(NASDAQ: QNRX) Quoin Pharmaceuticals trades on the NASDAQ under the ticker symbol QNRX. Quoin Pharmaceuticals stock quotes can also be displayed as NASDAQ: QNRX.

If you're new to stock investing, here's how to buy Quoin Pharmaceuticals stock.

What is the 52 week high and low for Quoin Pharmaceuticals (NASDAQ: QNRX)?

(NASDAQ: QNRX) Quoin Pharmaceuticals's 52-week high was $31.40, and its 52-week low was $3.33. It is currently -78.44% from its 52-week high and 103.4% from its 52-week low.

How much is Quoin Pharmaceuticals stock worth today?

(NASDAQ: QNRX) Quoin Pharmaceuticals currently has 20,585,830 outstanding shares. With Quoin Pharmaceuticals stock trading at $6.77 per share, the total value of Quoin Pharmaceuticals stock (market capitalization) is $6.97M.

Quoin Pharmaceuticals stock was originally listed at a price of $318,001.27 in Aug 1, 2016. If you had invested in Quoin Pharmaceuticals stock at $318,001.27, your return over the last 8 years would have been -100%, for an annualized return of -73.94% (not including any dividends or dividend reinvestments).

How much is Quoin Pharmaceuticals's stock price per share?

(NASDAQ: QNRX) Quoin Pharmaceuticals stock price per share is $6.77 today (as of Apr 30, 2025).

What is Quoin Pharmaceuticals's Market Cap?

(NASDAQ: QNRX) Quoin Pharmaceuticals's market cap is $6.97M, as of May 1, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Quoin Pharmaceuticals's market cap is calculated by multiplying QNRX's current stock price of $6.77 by QNRX's total outstanding shares of 20,585,830.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.